menu
    • menu

    Company profile for Whitehawk Therapeutics

    NEW Drugs in Dev: 4
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Whitehawk Therapeutics is a preclinical-stage oncology company leveraging cutting-edge technologies and well-established tumor biology to develop more effective cancer treatments. The company’s innovative three-asset antibody-drug conjugate (ADC) portfolio is designed to address the limitations of earlier-generation ADCs, aiming to make a significant difference for patients facing hard-to-treat cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Whitehawk TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2 Headquarters Plaza, East Building, 11th Floor Morristown, NJ 07960
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.whitehawktx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/whitehawk-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Whitehawk Therapeutics Showcases Next-Gen ADC Portfolio Data
    Whitehawk Therapeutics Showcases Next-Gen ADC Portfolio Data

    20 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-presents-comprehensive-preclinical-data-highlighting-its-next-generation-adc-portfolio-at-the-aacr-2026-302746115.html

    PR NEWSWIRE
    20 Apr 2026
    Share Share
    Whitehawk Identifies MUC16 As Key Target for Gynecologic Cancers
    Whitehawk Identifies MUC16 As Key Target for Gynecologic Cancers

    10 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-presents-real-world-analysis-confirming-muc16-as-a-highly-expressed-clinically-relevant-target-for-gynecologic-cancers-at-sgo-2026-302738766.html

    PR NEWSWIRE
    10 Apr 2026
    Share Share
    Whitehawk Therapeutics Showcases Next-Gen ADC Portfolio At AACR
    Whitehawk Therapeutics Showcases Next-Gen ADC Portfolio At AACR

    18 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-highlight-its-next-generation-adc-portfolio-at-the-american-association-for-cancer-research-aacr-annual-meeting-2026-302716323.html

    PR NEWSWIRE
    18 Mar 2026
    Share Share
    Whitehawk Therapeutics Reports Q4 FY 2025 Results and Highlights
    Whitehawk Therapeutics Reports Q4 FY 2025 Results and Highlights

    12 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-and-recent-highlights-302711592.html

    PR NEWSWIRE
    12 Mar 2026
    Share Share
    Whitehawk Presents at 36th Oppenheimer Healthcare Conference
    Whitehawk Presents at 36th Oppenheimer Healthcare Conference

    18 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference-302691346.html

    PR NEWSWIRE
    18 Feb 2026
    Share Share
    Tempus Achieves Record Total Contract Value Exceeding $1.1 B
    Tempus Achieves Record Total Contract Value Exceeding $1.1 B

    11 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260111285444/en/Tempus-Achieves-Record-Total-Contract-Value-Exceeding-%241.1-Billion

    BUSINESSWIRE
    11 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search